{"actinic keratosis": 21.46, "alanine aminotransferase increased": 2.69, "arthritis": 3.14, "ascites": 2.44, "aspartate aminotransferase increased": 2.63, "aspergillus infection": 8.63, "basal cell carcinoma": 8.1, "blood alkaline phosphatase increased": 2.1, "blood bilirubin increased": 2.23, "blood creatinine increased": 3.23, "bone marrow failure": 3.43, "bronchopulmonary aspergillosis": 5.41, "c-reactive protein abnormal": 13.45, "c-reactive protein increased": 3.35, "candida infection": 4.68, "cellulitis": 2.44, "cholestasis": 2.22, "chronic graft versus host disease": 20.29, "clear cell renal cell carcinoma": 34.46, "clostridium difficile infection": 2.81, "colitis": 10.08, "colitis ulcerative": 11.78, "condition aggravated": 2.24, "contraindicated product administered": 3.63, "crohn's disease": 11.33, "cushingoid": 12.81, "cytomegalovirus infection": 13.05, "cytomegalovirus infection reactivation": 10.76, "cytomegalovirus test positive": 13.69, "cytomegalovirus viraemia": 14.86, "cytopenia": 2.38, "diffuse large b-cell lymphoma": 5.1, "disease recurrence": 3.26, "drug hypersensitivity": 4.85, "drug ineffective": 3.62, "drug ineffective for unapproved indication": 7.17, "drug intolerance": 9.63, "drug-induced liver injury": 2.47, "eosinophilic granulomatosis with polyangiitis": 6.38, "epstein-barr virus infection": 26.23, "exposure during pregcy": 2.64, "foetal anaemia": 461.84, "foetal exposure during pregcy": 3.22, "foetal growth restriction": 13.17, "frequent bowel movements": 4.96, "gastrointestinal disorder": 2.95, "graft versus host disease": 5.28, "haemodialysis": 11.36, "haemophagocytic lymphohistiocytosis": 7.49, "haemorrhage foetal": 438.43, "haemorrhage in pregcy": 45.32, "heart transplant rejection": 42.0, "hepatic enzyme increased": 2.97, "hepatitis": 2.75, "hepatitis c": 2.01, "hepatitis cholestatic": 3.7, "hepatosplenomegaly": 12.87, "hepatotoxicity": 5.22, "herpes simplex": 9.1, "immunosuppression": 8.42, "inflammation": 5.61, "inflammatory bowel disease": 7.42, "infusion site thrombosis": 153.78, "interstitial lung disease": 2.02, "joint stiffness": 2.13, "joint swelling": 2.85, "kidney transplant rejection": 22.58, "leukopenia": 3.43, "live birth": 22.09, "liver function test abnormal": 6.32, "liver function test increased": 4.25, "low birth weight baby": 5.09, "lung infiltration": 3.97, "lymphocyte count decreased": 3.71, "lymphoma": 2.39, "lymphopenia": 4.21, "maternal exposure during pregcy": 4.88, "myopathy": 3.87, "myositis": 3.07, "nephropathy toxic": 5.11, "neutrophil count increased": 6.64, "night sweats": 6.06, "nocardiosis": 20.85, "normal newborn": 12.75, "obstruction": 19.62, "off label use": 2.55, "pancreatitis": 4.18, "pancytopenia": 3.7, "pneumocystis jirovecii pneumonia": 5.41, "polyomavirus-associated nephropathy": 21.75, "post transplant lymphoproliferative disorder": 30.99, "pregcy": 4.74, "premature baby": 7.72, "premature delivery": 9.77, "premature labour": 19.94, "product use in unapproved indication": 2.19, "proteinuria": 2.25, "pulmonary mass": 3.44, "quality of life decreased": 4.19, "red blood cell sedimentation rate abnormal": 30.5, "red blood cell sedimentation rate increased": 7.3, "renal transplant failure": 49.73, "rheumatoid arthritis": 2.05, "scleroderma": 10.05, "sepsis": 2.65, "septic shock": 3.54, "skin infection": 11.53, "skin lesion": 3.59, "skin mass": 6.03, "splenomegaly": 6.14, "squamous cell carcinoma of skin": 19.29, "staphylococcal infection": 2.47, "synovitis": 9.95, "systemic lupus erythematosus": 3.54, "therapeutic product effect decreased": 11.89, "therapeutic product effect incomplete": 5.45, "therapy non-responder": 2.44, "thrombotic microangiopathy": 4.38, "transaminases increased": 2.85, "transplant rejection": 14.59, "treatment failure": 14.87, "tuberculosis": 4.43, "tubulointerstitial nephritis": 2.53, "vasculitis": 3.77, "viral infection": 2.33, "weight decreased": 3.01}